Hatto - thanks for the kind words. I should stress that I am a CD patient, but my wifes interest in RA is professional. She of course has the added stress of living with me but it will take more than a monoclonal antibody to treat that affliction!
As I see it, the market is likely, over the course of the coming months and years, to be flooded with new monoclonal antibody treatments targetting a variety of ailments. I suspect the personal interest is what I find particularly attractive here, and with my optimistic hat on, what a lovely thought it would be to successfully invest in something which later went on to benefit my own health!